Enterprise Systems (Healthcare) · Pittsburgh, PA · Founded 2018 · Privately Held (backing)
Developer of an AI-powered conversation analysis application designed to bring context and understanding to every medical conversation. Abridge is based in Pittsburgh, PA and was founded in 2018. It is valued at about $6.7 billion as of Oct 2026, set by secondary market price, up 26% since its later-stage round in Jun 2025. It has raised $758 million across 3 recorded rounds; the latest was a $250 million Series D in Feb 2025.
PMV mark · valuation
$6.7B
Oct 2026
Secondary market · $/share
$200
Total raised
$758.0M
Last round
Later Stage VC (Series D)
Feb 2025
Secondary market
monthly marks · 34 months · Jan 2024 – Oct 2026
Current
▮
High
▮
Low
▮
▮▮
Jan 2024marks: indicative $/share, month-end · as of Oct 15, 2026Oct 2026
Monthly marks are a Pro feature — the shape is real, the numbers are waiting.Unlock 34 monthly marks
Membership and data by Private Market View
Prints on record
1
Price range
▮
Latest print
Dec 2025
First print
Dec 2025
Pro
The prices on Abridge
·Every dated print: 1 trade with prices and structures
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Abridge stock.
